10 Unusual Stocks Attracting Huge Interest In The Pre-Market Right Now

scientist stimulus tbi

Here’s where we see the heat today:

A potential IBM acquisition, an overnight two-bagger in the pharma space, how BHP could be forced to pay more for Potash, and more…

M&A: BHP (BHP) could be forced to bid higher for Potash (POT)

EARNINGS: Health care firm Humana (HUM) hikes guidance

EARNINGS: Driller Baker Hughes (BHI) blows away expectations

EARNINGS: Cinema firm Loews (L) just beats expectations

PHARMA CATALYST: Avanir (AVNR) becomes an overnight two-bagger after a product gets FDA clearance

Enormous volume in the pre-market. Read about it here.

DEAL CATALYST: Trucking form YRC melting up after the firm won a key concession with union members over the weekend

M&A: Fortinent (FTNT) reportedly approached by IBM (IBM) for a takeover, stock soaring

EARNINGS: Anadarko Petroleum (APC) reports today after the close

EARNINGS: Semiconductor firm Anadigics beats estimates, but guidance disappoints. Stock diving.

PHARMA CATALYST: Biodel (BIOD) crashing after a product is rejected by the FDA

EARNINGS: Corning (GLW) misses expectations, dropping

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.